5-hydroxymethyl-2'-deoxyuridine has been researched along with Hypersensitivity, Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frenkel, K; Karkoszka, J; Khasak, D; Sasson, M; Shupack, JL; Stiller, MJ | 1 |
1 other study(ies) available for 5-hydroxymethyl-2'-deoxyuridine and Hypersensitivity, Type III
| Article | Year |
|---|---|
Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Cell Survival; Humans; Immune Complex Diseases; Molecular Structure; Oxidation-Reduction; Psoriasis; Thymidine; Titrimetry; Ultraviolet Therapy | 1993 |